Clinical characteristics and outcome of immunoglobulin M-related disorders

Clinical Lymphoma

Volumn 5, Issue 4, 2005, Pages 261-264

  Cesana, Clara ^a,b   Barbarano, Luciana ^a   Miqueleiz, Sara ^a   Lucchesini, Camilla ^a   Ricci, Francesca ^a   Varettoni, Marzia ^c   Filippini, Davide ^a   Lazzarino, Mario ^c   Morra, Enrica ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Servizio di Fisiopatologia Respiratoria G Campari   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cryoglobulinemia; Idiopathic thrombocytopenic purpuras; Waldenstr m's macroglobulinemia

Indexed keywords

BENCE JONES PROTEIN; BETA 2 MICROGLOBULIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; STEROID;

ADULT; AGE; AGED; ARTHRALGIA; ARTICLE; B CELL LEUKEMIA; BLOOD CELL COUNT; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; CRYOGLOBULINEMIA; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HEPATOMEGALY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; LONG TERM CARE; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MONOCLONAL IMMUNOGLOBULINEMIA; MORTALITY; NONHODGKIN LYMPHOMA; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PROBABILITY; PROGNOSIS; PROTEINURIA; PURPURA; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SPLENOMEGALY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WALDENSTROEM MACROGLOBULINEMIA;

EID: 18144415466     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2005.n.012     Document Type: Article

References (20)

1. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 2003; 30:110-115.
2. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
3. Galli M. Viruses and cryoglobulinemia. Clin Exp Rheumatol 1995; 13(suppl 13):S63-S70.
4. Dammacco F, Sansonno D, Piccoli C, et al. The cryoglobulins: an overview. Eur J Clin Invest 2001; 31:628-638.
5. Kitay-Cohen Y, Amiel A, Hilzenrat N, et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 2000; 96:2910-2912.
6. Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117:573-577.
7. Hausfater P, Cacoub P, Rosenthal E, et al. Hepatitis C virus infection and lymphoproliferative disease in France: a national study. The GERMIVIC Group. Am J Hematol 2000; 64:107-111.
8. Sansonno D, Cornacchiulo V, Iacobelli AR, et al. Hepatitis C virus infection and clonal B-cell expansion. Clin Exp Rheumatol 1996; 14(suppl 14):S45-S50.
9. Vital A. Paraproteinemic neuropathies. Brain Pathol 2001; 11:399-407.
10. Stone MJ, McElroy YG, Pestronk A, et al. Human monoclonal macroglobulins with antibody activity. Semin Oncol 2003; 30:318-324.
11. Owen RG, Lubenko A, Savage J, et al. Autoimmune thrombocytopenia in Waldenstrom's macroglobulinemia. Am J Hematol 2001; 66:116-119.
12. Migliaresi S, Di Iorio G, Ammendola A, et al. Peripheral nervous system involvement in HCV-related mixed cryoglobulinemia. Reumatismo 2001; 53:26-32.
13. Drees C, Grond M, Szelies B, et al. Polyneuropathies in monoclonal gammopathy of undetermined significance: initial manifestation of a lymphoma. Med Klin 1997; 92:112-116.
14. Nobile-Orazio E, Meucci N, Baldini L, et al. Long-term prognosis of neuropathy associated with anti-MAG IgM-proteins and its relationship to immune therapies. Brain 2000; 123:710-717.
15. Cesana C, Klersy C, Barbarano L, et al. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. J Clin Oncol 2002; 20:1625-1634.
16. van de Poel MH, Coebergh JW, Hillen HF. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital of Southeastern Netherlands. Br J Haemathol 1995; 91:121-125.
17. Morra E, Cesana C, Klersy C, et al. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders. Leukemia 2004; 18:1512-1517.
18. Alexanian R, Weber D, Delasalle K, et al. Asymptomatic Waldenstrom's macroglobulinemia. Semin Oncol 2003; 30:206-210.
19. Cesana C, Miqueleiz S, Bernuzzi P, et al. Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease. Semin Oncol 2003; 30:231-235.
20. Kyle RA, Therneau TM, Rajkumar SV, et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003; 102:3759-3764.